3 results
Approved WMOPending
To evaluate the efficacy and safety of nilotinib in spondyloarthritis
Approved WMOPending
The major aim of this study is changes in tinnitus loudness (daily report mark) and annoyance (daily report mark) and the duration of this change (time).
Approved WMORecruiting
The primary objective of this study is: Part 1: To evaluate the efficacy of AL001 compared with placebo as measured by CDR® plus NACC FTLD-SB.Part 2: To assess the long-term safety and tolerability of AL001 in participants who have completed 96…